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Introduction
In medication-overuse headache (MOH) pain modulation
is probably dysfunctional at cortical and subcortical level,
resulting in disequilibrium between pain inhibition and
facilitation. Volumetric grey matter changes have been
found in cortical regions, but also in the brainstem [2], the
latter being reversible after successful detoxification [1].
Aims
Surface-based morphometric analyses should complement
volumetric findings, providing more specificity in the
metric affected (thickness vs. gyrification). Whereas corti-
cal thickness alterations probably rely on altered trajec-
tories of cortical maturation or neurodegenerative
processes, cortical folding (gyrification) abnormalities are
thought to reflect early alterations to brain development.
Methods
In the present study we investigated cortical thickness and
gyrification in 29 patients with MOH according to Inter-
national Headache Society criteria and 29 age- and gender
matched controls, using FreeSurfer. Correction for multi-
ple comparisons was performed.
Results
In patients with MOH cortical thickness was decreased in
the left middle frontal gyrus (rostral part) compared to
controls, whereas local gyrification was increased in the
right fusiform gyrus and adjacent temporal regions, as well
as in the right occipital pole.
Conclusions
Decreased cortical thickness in frontal regions corresponds
to decreased grey matter volume in similar regions.
Increased local gyrification in the right fusiform gyrus cor-
responds to increased grey matter volume in the previous
volumetric study. Increased gyrification in occipital
regions might be related to increased susceptibility for cor-
tical spreading depression.
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